Maxygen
Get Full AccessDescription
- Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs through internal development and external collaborations and other arrangements. We use the MolecularBreeding directed evolution technology platform, along with ancillary technologies, and extensive protein modification expertise to pursue the creation of biosuperior proteins. Maxygen operates substantially all of its research and development operations through Perseid Therapeutics LLC, or Perseid, a majority-owned subsidiary established in September 2009 in connection with a joint venture arrangement with Astellas Pharma Inc., or Astellas. Perseid is focused on the discovery, research and development of multiple protein pharmaceutical programs, including CTLA-4 Ig product candidates that are designed to be superior, next-generation CTLA-4 Ig therapeutics for the treatment of a broad array of autoimmune disorders, including rheumatoid arthritis, and transplant rejection.
-
Headquarters:725 San Aleso Avenue , Sunnyvale, California, United States
More -
Phone Number:
-
Website: https://www.maxygen.com
-
Employees:81
-
Revenue:$100 - 250M
-
Legal Name:Maxygen
-
Maxygen's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Maxygen
-
Where are Maxygen's Headquarters?
Maxygen's Headquarters are in 725 San Aleso Avenue ,Sunnyvale,California,United States
-
What is Maxygen's official website?
Maxygen's official website is https://www.maxygen.com
-
What is Maxygen's Revenue?
Maxygen's revenue is $100 - 250M
-
What is Maxygen's NAICS code?
Maxygen's NAICS code is 541713
-
How many employees are working in Maxygen
Maxygen has 81 employees
-
What is Maxygen's Industry?
Maxygen is in the industry of Biotechnology
-
Who is Maxygen's CEO?
Maxygen's CEO is Russell Howard
-
Who is Maxygen's President?
Maxygen's President is Sylvie Blanchette

